semaglutide Explainer: What's behind the scramble
Description
Approximately 86% of patients who received tirzepatide achieved an HbA1c level of less than 7.0%
(NCBI) That distinction matters
For these patients, semaglutide offers a clinically proven way to reduce weight and lower the risk of related conditions such as cardiovascular disease, sleep apnea, and joint problems
Reference: OFarrell M, et al
.webp?width=900&height=1201&name=Semaglutide%20Image%202_900x1200%20(without%20phone).webp)
Bai X, Yan J, Gilchrest BA
Minimal bruising, and no redness or irritation
